Table 1. Clinical features of patients carrying bla _NDM-1.

Patient	1 (pLK-75, CR-KP)	2 (pLK-78, CR-EC)
Age	82	64
Gender	Male	Female
Underlying disease	HTN, CAD, pulmonary TB, HBV, CKD, Parkinsonism	HTN, DM, stroke and ESRD with HD, schizophrenia
Admission period	2012/09/05∼2012/10/10	2012/05/28∼2012/10/24
Clinical diagnosis	Pneumonia	Pneumonia, septic shock, respiratory failure
NDM-1 bacteria isolation date	2012/09/24	2012/09/29
Source	Sputum	Sputum
Antibiotics	Ceftriaxone (9/4∼9/5), Piperacillin/Tazobactam (9/6∼9/20), Ciprofloxacin (9/24∼9/26), Ertapenem (9/27∼10/2), Isoniazid (6/28∼), Rifampin (6/28∼)	Piperacillin/Tazobactam (9/4∼9/19), Levofloxacin (9/14∼9/27), Linezolid (9/19∼10/1) Imipenem/Cilastatin (9/28∼10/2), Ceftriaxone (10/3∼10/11), Daptomycin (10/3∼10/17), Cefepime (10/12∼10/26)
Outcome	Improved	Improved

Abbreviations: HTN, hypertension; CAD, coronary artery disease; TB, tuberculosis; HBV, hepatitis B; CKD, chronic kidney disease; ESRD, end-stage renal disease; HD, haemodialysis.